{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:43:48Z","timestamp":1792791828355,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":3648,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1111\/j.1469-0691.2006.01398.x","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T08:27:34Z","timestamp":1145348854000},"page":"67-80","source":"Crossref","is-referenced-by-count":43,"special_numbering":"S3","title":["Current challenges in the treatment of complicated urinary tract infections and prostatitis"],"prefix":"10.1016","volume":"12","author":[{"given":"F.M.E.","family":"Wagenlehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.G.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2006.01398.x_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1A","key":"10.1111\/j.1469-0691.2006.01398.x_bib2","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0022-5347(05)64397-2","article-title":"Resistance trends in urinary tract pathogens and impact on management","volume":"168","author":"Mazzulli","year":"2002","journal-title":"J Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/45.3.295","article-title":"Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998)","volume":"45","author":"Gales","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01713142","article-title":"Nosocomial and community\u2010acquired infections in Germany. Summary of the results of the first national prevalence study (NIDEP)","volume":"25","author":"R\u00fcden","year":"1997","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid0702.010240","article-title":"Engineering out the risk of infection with urinary catheters","volume":"7","author":"Maki","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0025-7125(16)30466-7","article-title":"Urinary tract infection: economic considerations","volume":"75","author":"Patton","year":"1991","journal-title":"Med Clin North Am"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0732-8893(98)00158-8","article-title":"Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997","volume":"35","author":"Jones","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0732-8893(02)00467-4","volume":"45","author":"Gordon","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0732-8893(01)00254-1","article-title":"Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America)","volume":"40","author":"Mathai","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1198-743x.2001.00326.x","article-title":"A European perspective on nosocomial urinary tract infections. I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI\u2010003 study)","volume":"7","author":"Bouza","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0924-8579(02)00100-0","article-title":"Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994\u20132000","volume":"19","author":"Wagenlehner","year":"2002","journal-title":"Int J Antimicrobial Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib13","author":"Bjerklund Johansen"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0924-8579(99)00046-1","article-title":"Prostatitis: US Perspective","volume":"11","author":"Schaeffer","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH Consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1111\/j.1469-0691.2006.01398.x_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01643680","article-title":"Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients","volume":"19","author":"Weidner","year":"1991","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib17","series-title":"Infectious Diseases","first-page":"1","article-title":"Prostatitis, epididymitis and orchitis","author":"Naber","year":"1999"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0195-6701(00)90821-1","article-title":"Hospital\u2010acquired urinary tract infections","volume":"46","author":"Wagenlehner","year":"2000","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJM199310283291808","article-title":"Management of urinary tract infections in adults","volume":"329","author":"Stamm","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01398.x_bib20","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/318844","article-title":"Urinary tract pathogens in complicated infection and in elderly individuals","volume":"183","author":"Nicolle","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.111.3.676","article-title":"Impact of BAL data on the therapy and outcome of ventilator\u2010associated pneumonia","volume":"111","author":"Luna","year":"1997","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/clinids\/23.3.486","article-title":"Emergence of antibiotic\u2010resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy","volume":"23","author":"Montravers","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0163-4453(97)93194-7","article-title":"Empiric antibiotic treatment and the missuse of culture results and antibiotic sensitivities in patients with community\u2010acquired bacteraemia due to urinary tract infection","volume":"35","author":"Elhanan","year":"1997","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0924-8579(00)00222-3","article-title":"In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections","volume":"16","author":"Naber","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2165\/00003495-200464120-00007","article-title":"Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections","volume":"64","author":"Carson","year":"2004","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib26","first-page":"492","article-title":"Bacteriologic localization patterns in bacterial prostatitis and urethris","volume":"5","author":"Meares","year":"1968","journal-title":"Invest Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib27","first-page":"38","article-title":"The Pre and Post Massage Test (PPMT): a simple screen for prostatitis","volume":"3","author":"Nickel","year":"1997","journal-title":"Tech Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-200118040-00002","article-title":"A practical guide to antimicrobial management of complicated urinary tract infection","volume":"18","author":"Nicolle","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000049840","article-title":"EAU guidelines for the management of urinary and male genital tract infections","volume":"40","author":"Naber","year":"2001","journal-title":"Eur Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib30","first-page":"78","article-title":"Infektionen der Nieren und des Urogenitaltraktes","volume":"13","author":"Naber","year":"2004","journal-title":"Chemotherapie J"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib31","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-5347(05)67697-5","article-title":"Gentamicin for the practicing urologist: review of efficacy, single daily dosing and \u2018switch\u2019 therapy","volume":"163","author":"Santucci","year":"2000","journal-title":"J Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0924-8579(00)00362-9","article-title":"Which fluoroquinolones are suitable for the treatment of urinary tract infections?","volume":"17","author":"Naber","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0924-8579(02)00105-X","article-title":"Correlation between pharmacokinetic\/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection","volume":"19","author":"Frimodt\u2010Moller","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid0901.020277","article-title":"Maintaining fluoroquinolone class efficacy: review of influencing factors","volume":"9","author":"Scheld","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01398.x_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijantimicag.2003.09.006","article-title":"Urinary bactericidal activity, urinary excretion and plasma concentrationsof gatifloxacin (400mg) versus ciprofloxacin(500mg) in healthy volunteers after a single oral dose","volume":"23","author":"Boy","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-5347(17)61919-0","article-title":"Chronic bacterial prostatitis and the diffusion of drugs into the prostatic fluid","volume":"103","author":"Stamey","year":"1970","journal-title":"J Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01646071","article-title":"Interaction between antimicrobial agents and prostatic tissue extract and fluid","volume":"6","author":"Madsen","year":"1978","journal-title":"Infection"},{"issue":"Suppl","key":"10.1111\/j.1469-0691.2006.01398.x_bib38","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/infdis\/128.Supplement_3.S686","article-title":"The concentration of trimethoprim in prostatic fluid: non\u2010ionic diffusion or active transport?","volume":"129","author":"Stamey","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0090-4295(76)90339-3","article-title":"Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole. Experimental and clinical studies","volume":"8","author":"Madsen","year":"1976","journal-title":"Urology"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib40","series-title":"Therapy of Prostatitis. Experimental and Clinical Data","first-page":"50","article-title":"The influence of various body fluids and pH on E. coli MIC of quinolone derivatives","author":"Gasser","year":"1986"},{"issue":"Suppl. 20","key":"10.1111\/j.1469-0691.2006.01398.x_bib41","first-page":"25","article-title":"Pharmakokinetik der Chinolone","volume":"11","author":"S\u00f6rgel","year":"2002","journal-title":"Chemotherapie J"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF01739308","article-title":"Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid","volume":"21","author":"Naber","year":"1993","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib43","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0022-5347(17)35877-9","article-title":"Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg","volume":"150","author":"Naber","year":"1993","journal-title":"J Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib44","series-title":"Quinolone Antimicrobial Agents","first-page":"285","article-title":"Role of quinolones in treatment of chronic bacterial prostatitis","author":"Naber","year":"1993"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.45.1.293-297.2001","article-title":"Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administration of 400 milligrams to volunteers","volume":"45","author":"Naber","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib46","series-title":"Macrolides. Chemistry, Pharmacology and Clinical Uses","first-page":"421","article-title":"Physiological disposition of macrolides","author":"S\u00f6rgel","year":"1993"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF01643681","article-title":"Rat model of experimental bacterial prostatitis","volume":"19","author":"Nickel","year":"1991","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib48","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0022-5347(05)67145-5","article-title":"Bacterial DNA sequences in postate tissue from patients with prostate cancer and chronic prostatitis","volume":"164","author":"Krieger","year":"2000","journal-title":"J Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-4295(93)90584-W","article-title":"Diagnosis and treatment of 409 patients with prostatitis syndromes","volume":"41","author":"De la Rosette","year":"1993","journal-title":"Urology"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000282530","article-title":"Antimicrobial treatment for chronic prostatitis as a means of defining the role of Ureaplasma urealyticum","volume":"51","author":"Ohkawa","year":"1993","journal-title":"Urol Int"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000019784","article-title":"The role of antibiotics in the treatment of chronic prostatitis: a consensus statement","volume":"34","author":"Bjerklund Johansen","year":"1998","journal-title":"Eur Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib52","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.35.9.1849","article-title":"Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study","volume":"35","author":"Fang","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02014003","article-title":"Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection","volume":"5","author":"Peters","year":"1986","journal-title":"Eur J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF01704616","article-title":"Sequential therapy with ofloxacin in complicated urinary tract infections: a randomized comparative study with ciprofloxacin","volume":"20","author":"Peters","year":"1992","journal-title":"Infection"},{"issue":"Suppl. A","key":"10.1111\/j.1469-0691.2006.01398.x_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/37.suppl_A.135","article-title":"Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection","volume":"37","author":"Naber","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archinte.159.1.53","article-title":"Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial","volume":"159","author":"Mombelli","year":"1999","journal-title":"Arch Intern Med"},{"issue":"Suppl. 2","key":"10.1111\/j.1469-0691.2006.01398.x_bib57","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2165\/00003495-199500492-00101","article-title":"A randomised controlled trial of ofloxacin 200 mg 4 times daily or twice daily vs ciprofloxacin 500 mg twice daily in elderly nursing home patients with complicated UTI","volume":"49","author":"McCue","year":"1995","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib58","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000239482","article-title":"Complicated urinary infection in spinal injury patients: fleroxacin compared with ciprofloxacin","volume":"42","author":"Whitby","year":"1996","journal-title":"Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib59","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1179\/joc.1996.8.3.210","article-title":"Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study","volume":"8","author":"Pisani","year":"1996","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s100960050488","article-title":"Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women","volume":"19","author":"Raz","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0924-8579(98)00088-0","article-title":"Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group","volume":"11","author":"Krcmery","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib62","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0022-5347(01)64252-6","article-title":"Once\u2010daily fleroxacin versus twice\u2010daily ciprofloxacin in the treatment of complicated urinary tract infections","volume":"158","author":"Frankenschmidt","year":"1997","journal-title":"J Urol"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01398.x_bib63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijantimicag.2003.09.002","article-title":"Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections","volume":"23","author":"Naber","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib64","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.ju.0000106191.11936.64","article-title":"Once\u2010daily extended release ciprofloxacin vs. conventional twice\u2010daily ciprofloxacin for the treatment of complicated urinary tract infections and acute uncomplicated pyelonephritis","volume":"171","author":"Talan","year":"2004","journal-title":"J Urol"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01398.x_bib65","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000238908","article-title":"Treatment of complicated urinary tract infections with ofloxacin following an aminoglycoside","volume":"37","author":"Matsumoto","year":"1991","journal-title":"Chemother"},{"issue":"Suppl. D","key":"10.1111\/j.1469-0691.2006.01398.x_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/26.suppl_D.93","article-title":"Comparison of i.v. ofloxacin and piperacillin in the treatment of complicated urinary tract infections","volume":"26","author":"Schalkhauser","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib67","doi-asserted-by":"crossref","first-page":"118S","DOI":"10.1016\/S0002-9343(20)31151-7","article-title":"Comparison of intravenous fleroxacin with ceftazidime for treatment of complicated urinary tract infections","volume":"94","author":"Cox","year":"1993","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib68","doi-asserted-by":"crossref","first-page":"101S","DOI":"10.1016\/S0002-9343(20)31147-5","article-title":"Randomized double\u2010blind trial of high\u2010 and low\u2010dose fleroxacin versus norfloxacin for complicated urinary tract infection","volume":"94","author":"Pittman","year":"1993","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib69","doi-asserted-by":"crossref","first-page":"126S","DOI":"10.1016\/S0002-9343(20)31152-9","article-title":"A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection","volume":"94","author":"Gelfand","year":"1993","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01398.x_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000239488","article-title":"Fleroxacin in complicated urinary tract infections","volume":"42","author":"Giamarellou","year":"1996","journal-title":"Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib71","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1128\/AAC.38.6.1368","article-title":"Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim\u2010sulfamethoxazole","volume":"38","author":"Nicolle","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib72","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01964430","article-title":"Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections","volume":"12","author":"Hoepelman","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0149-2918(95)80114-6","article-title":"Comparison of enoxacin versus trimethoprim\u2010sulfamethoxazole in the treatment of patients with complicated urinary tract infection","volume":"17","author":"Gottlieb","year":"1995","journal-title":"Clin Ther"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib74","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0090-4295(97)00708-5","article-title":"A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection","volume":"51","author":"Klimberg","year":"1998","journal-title":"Urology"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib75","first-page":"33","article-title":"Randomized, double\u2010blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections","volume":"32","author":"Peng","year":"1999","journal-title":"J Microbiol Immunol Infect"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01398.x_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01716050","article-title":"Proposed study design in prostatitis","volume":"22","author":"Naber","year":"1994","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib77","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0022-5347(17)39556-3","article-title":"The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim\u2010sulfamethoxazole and\/or carbenicillin","volume":"144","author":"Schaeffer","year":"1990","journal-title":"J Urol"},{"issue":"Suppl. 4","key":"10.1111\/j.1469-0691.2006.01398.x_bib78","first-page":"867","article-title":"Efficacy of long\u2010term therapy with norfloxacin in chronic bacterial prostatitis","volume":"1","author":"Peppas","year":"1989","journal-title":"J Chemother"},{"issue":"Suppl. 4","key":"10.1111\/j.1469-0691.2006.01398.x_bib79","first-page":"469","article-title":"Clinical efficacy of ofloxacin (Tarivid) in patients with chronic bacterial prostatitis: preliminary results","volume":"1","author":"Pust","year":"1989","journal-title":"J Chemother"},{"issue":"Suppl. 4A","key":"10.1111\/j.1469-0691.2006.01398.x_bib80","first-page":"280","article-title":"Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one\u2010year follow\u2010up study","volume":"82","author":"Weidner","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib81","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0022-5347(17)37791-1","article-title":"Refractory chronic bacterial prostatitis: a re\u2010evaluation of ciprofloxacin treatment after a median follow\u2010up of 30 months","volume":"146","author":"Weidner","year":"1991","journal-title":"J Urol"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1061486","article-title":"Therapie der unteren Harnwegsinfektionen beim Mann unter besonderer Ber\u00fccksichtigung der chronischen bakteriellen Prostatitis","volume":"18","author":"Pfau","year":"1987","journal-title":"Akt Urol"},{"issue":"Suppl. 3","key":"10.1111\/j.1469-0691.2006.01398.x_bib83","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF01643689","article-title":"The treatment of chronic bacterial prostatitis","volume":"19","author":"Pfau","year":"1991","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib84","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(99)00142-9","article-title":"Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non\u2010comparative multicentre clinical trial with long\u2010term follow\u2010up","volume":"14","author":"Naber","year":"2000","journal-title":"Int J Antimicr Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0924-8579(02)00067-5","article-title":"Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis","volume":"20","author":"Naber","year":"2002","journal-title":"Int J Antimicr Agents"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib86","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","article-title":"National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of new outcome measure","volume":"162","author":"Litwin","year":"1999","journal-title":"J Urol"},{"issue":"3","key":"10.1111\/j.1469-0691.2006.01398.x_bib87","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-4295(03)00565-X","article-title":"Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double\u2010blind multicenter study","volume":"62","author":"Bundrick","year":"2003","journal-title":"Urology"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib88","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0732-8893(01)00287-5","article-title":"Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different","volume":"41","author":"Jones","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib89","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0891-5520(05)70374-3","article-title":"Complicated urinary tract infections","volume":"11","author":"Ronald","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1469-0691.2006.01398.x_bib90","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0924-8579(00)00168-0","article-title":"Complicated urinary tract infections","volume":"15","author":"Melekos","year":"2000","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T17:53:05Z","timestamp":1627235585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14613239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":90,"alternative-id":["S1198743X14613239"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01398.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}